UK Contraceptive Devices Market Size
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 395.62 Million |
Market Size (2029) | USD 524.45 Million |
CAGR (2024 - 2029) | 5.80 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
UK Contraceptive Devices Market Analysis
The United Kingdom Contraceptive Devices Market size is estimated at USD 395.62 million in 2024, and is expected to reach USD 524.45 million by 2029, growing at a CAGR of 5.80% during the forecast period (2024-2029).
- The COVID-19 pandemic had a negative impact on the growth of the studied market due to disruptions in global supply chains. According to an article published in March 2022 in Contraception and Reproductive Medicine, the use of long-acting contraceptives decreased significantly during the initial phase of the pandemic. Implants decreased by 76%, intrauterine systems by 79%, and intrauterine devices by 76%.
- Over the first three months of the lockdown, prescriptions for intrauterine and implant contraceptives decreased by 75%, which led to an increase in unwanted pregnancies in the country. A news report published in October 2021 revealed that women were nine times more likely to experience access issues to contraception during the first lockdown. This issue led to a near doubling of unexpected births from 1.3% before the lockdown to 2.1% post-lockdown.
- However, with the release of COVID-19 restrictions and the resumption of services, the market recovered post-pandemic, and a stable growth rate is expected during the forecast period. Several factors are propelling the market growth, including increasing awareness of sexually transmitted diseases (STDs), rising rates of unintended pregnancies, and an increase in government initiatives. The imperative of reducing unplanned pregnancies and their consequences is the key factor driving market growth in the United Kingdom.
- One of the significant drivers for this demand is the need to prevent unwanted pregnancies, particularly among teenage women. According to 2021 statistics published by the UK government, 214,256 abortions were reported in England and Wales in 2021. In addition, 89% of abortions were performed in women under 10 weeks in 2021 compared to 88% in the previous year, indicating a rising number of abortions in the country. This trend is expected to increase the demand for contraceptive devices among the population, thereby propelling the market growth.
- Strategic initiatives by market players also contribute to market growth. For instance, in December 2021, Gedeon Richter UK Ltd became a marketing authorization holder (MAH) for Evra, a once-weekly transdermal contraceptive patch for women of fertile age in the United Kingdom. Such authorizations are expected to increase the availability of contraceptive devices in the country during the forecast period.
- However, the side effects associated with the use of contraceptive devices are likely to restrain market growth over the forecast period. Despite this limitation, owing to factors such as rising demand for contraceptive devices and increasing awareness about these devices, the studied market is anticipated to witness growth over the analysis period.
UK Contraceptive Devices Market Trends
Condoms are Expected to Dominate the United Kingdom Contraceptive Devices Market
- The contraceptive devices market in the United Kingdom is expected to experience substantial growth in the condom segment over the forecast period. This growth can be attributed to several factors, including an increase in condom usage among the population and heightened awareness of sexually transmitted diseases within the country.
- A condom is a barrier device shaped like a sheath used during sexual activity to reduce the risk of pregnancy or sexually transmitted diseases (STDs). It is a widely used method of preventing STDs. For example, in March 2022, the National Chlamydia Screening Program (NCSP) was organized in the United Kingdom to reduce the risk of untreated chlamydia infection. The program aims to reduce the harms of untreated chlamydia infection by primarily screening women and girls. Such awareness initiatives are expected to drive the use of condoms for preventing unwanted pregnancy and STDs, thereby propelling the segment's growth.
- Furthermore, a clinical trial study published in the Journal of Sex Research in January 2022 in the United Kingdom showed that CSD500, a novel condom, holds significant potential for improving men's and women's sexual pleasure. Such studies are expected to drive growth in this segment further. In addition, condom sales have increased since lockdown restrictions eased in the United Kingdom, as reported in February 2022. The rise in condom sales is expected to further drive segment growth in the country during the forecast period.
High Prevalence of Sexually Transmitted Diseases and Increasing Awareness about STDs are Expected to Drive the Market Growth During
- The market growth for contraceptive devices in the country is expected to receive a boost from increased awareness about sexually transmitted diseases (STDs). This awareness is expected to break the social stigma surrounding these diseases and educate citizens about contraceptive devices for prevention.
- According to the United Kingdom's official report on STIs from 2021, updated in October 2022, there was a significant increase in consultations at Sexual Health Services (SHSs), with a total of 4,002,827 consultations in 2021, representing a 15.7% increase from the previous year. In addition, there were 1,949,940 sexual health screens, which are diagnostic tests for chlamydia, gonorrhea, syphilis, and human immunodeficiency virus (HIV) delivered by SHSs, representing an 18.7% increase compared to the previous year. These tests resulted in 311,604 diagnoses of new STIs among England residents in 2021.
- The high prevalence of STIs is expected to drive the use of contraceptive devices, such as condoms, which in turn is expected to boost the market growth in the country. The market growth is also expected to be fueled by various awareness initiatives being conducted in the country. For instance, in July 2022, a campaign with the theme 'It Starts With Me' was launched in England to raise awareness of HIV and sexually transmitted infections (STIs), as well as prevention strategies for these diseases. Such initiatives are expected to educate citizens about the risks and prevention methods of STIs, thereby creating opportunities for companies to develop innovative contraceptive devices that can be used to prevent STIs. This is expected to propel the market growth during the forecast period.
UK Contraceptive Devices Industry Overview
The contraceptive devices market in the United Kingdom is characterized by moderate competition. Key players in the industry include AbbVie Inc. (Allergan), Bayer AG, Cooper Surgical Inc., Pfizer, and Reckitt Benckiser, among others. To gain a competitive edge over generic products available in the market, companies are undertaking strategic initiatives such as increasing their investments in research and development of innovative products. This approach allows companies to introduce new and improved products that offer better efficacy and safety, thereby expanding their market share.
UK Contraceptive Devices Market Leaders
-
CooperSurgical, Inc.
-
AbbVie Inc. (Allergan)
-
Pfizer Inc.
-
Reckitt Benckiser
-
Bayer AG
*Disclaimer: Major Players sorted in no particular order
UK Contraceptive Devices Market News
- September 2022: Novo Nordisk, a key player in the pharmaceutical industry, launched an over-the-counter hormone replacement therapy drug in the United Kingdom. This move is expected to expand the company's portfolio and increase its market share in the hormone replacement therapy segment.
- July 2022: Organon, a global healthcare company, entered into a research collaboration and exclusive license agreement with Cirqle Biomedical, a Denmark-based company, to develop a novel investigational non-hormonal, on-demand contraceptive candidate. This collaboration is expected to leverage the strengths of both companies to develop innovative contraceptive products, thereby expanding their market share in the contraceptive market.
UK Contraceptive Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 High Prevalence of Sexually Transmitted Diseases and Increasing Awareness about STDs
- 4.2.2 Rising Rate of Unintended Pregnancies & Rise in Government Initiatives
-
4.3 Market Restraints
- 4.3.1 Side Effects Associated with the Use of Contraceptive Devices
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type
- 5.1.1 Condoms
- 5.1.2 Diaphragms
- 5.1.3 Cervical Caps
- 5.1.4 Vaginal Rings
- 5.1.5 Intra Uterine Device (IUD)
- 5.1.6 Other Types
-
5.2 By Gender
- 5.2.1 Male
- 5.2.2 Female
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AbbVie Inc. (Allergan)
- 6.1.2 Bayer AG
- 6.1.3 Cooper Surgical Inc.
- 6.1.4 Viatris (Mylan Laboratories)
- 6.1.5 Pfizer Inc.
- 6.1.6 Teva Pharmaceutical Industries Ltd
- 6.1.7 DKT International
- 6.1.8 Pregna International Limited
- 6.1.9 Reckitt Benckiser
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityUK Contraceptive Devices Industry Segmentation
As per the scope of the report, contraceptive devices have been barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide.
The United Kingdom's contraceptive devices market is segmented by type (condoms, diaphragms, cervical caps, vaginal rings, intrauterine devices (IUDs), and other types) and gender (male and female).
The report offers the value (in USD million) for the above segments.
By Type | Condoms |
Diaphragms | |
Cervical Caps | |
Vaginal Rings | |
Intra Uterine Device (IUD) | |
Other Types | |
By Gender | Male |
Female |
UK Contraceptive Devices Market Research FAQs
How big is the United Kingdom Contraceptive Devices Market?
The United Kingdom Contraceptive Devices Market size is expected to reach USD 395.62 million in 2024 and grow at a CAGR of 5.80% to reach USD 524.45 million by 2029.
What is the current United Kingdom Contraceptive Devices Market size?
In 2024, the United Kingdom Contraceptive Devices Market size is expected to reach USD 395.62 million.
Who are the key players in United Kingdom Contraceptive Devices Market?
CooperSurgical, Inc., AbbVie Inc. (Allergan), Pfizer Inc., Reckitt Benckiser and Bayer AG are the major companies operating in the United Kingdom Contraceptive Devices Market.
What years does this United Kingdom Contraceptive Devices Market cover, and what was the market size in 2023?
In 2023, the United Kingdom Contraceptive Devices Market size was estimated at USD 373.93 million. The report covers the United Kingdom Contraceptive Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the United Kingdom Contraceptive Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
APAC Fruits & Vegetables Juice Industry Report
Statistics for the 2024 APAC Fruits & Vegetables Juice market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. APAC Fruits & Vegetables Juice analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.